Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer
Mary Mazzotta Heckler(Georgetown University), Rebecca B. Riggins(Georgetown University), Tizita Zeleke(Icahn School of Medicine at Mount Sinai), Aykut Üren(Georgetown University), Jordan Woodrick(Georgetown University), Alexander Farzanegan(Georgetown University), Aileen I. Fernandez(Yale University), Shailaja D. Divekar, Susette C. Mueller(Unknown), Rabindra Roy(Georgetown University), Deanna Tiek(Northwestern University)
Cited by 17
Related Papers
Estrogen-Like Activity of Metals in Mcf-7 Breast Cancer Cells
|Endocrinology|2003|409
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
|JAMA Oncology|2022|347
Metals and Breast Cancer
|Journal of Mammary Gland Biology and Neoplasia|2013|210
Cadmium — A metallohormone?
|Toxicology and Applied Pharmacology|2009|191